These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9816163)

  • 1. Identification of a variant estrogen receptor lacking exon 4 and its coexpression with wild-type estrogen receptor in ovarian carcinomas.
    Park W; Choi JJ; Hwang ES; Lee JH
    Clin Cancer Res; 1996 Dec; 2(12):2029-35. PubMed ID: 9816163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of estrogen receptor mRNA and its alternatively spliced mRNAs in breast tumor cells and tissues.
    Fasco MJ
    Anal Biochem; 1997 Feb; 245(2):167-78. PubMed ID: 9056208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line.
    Castles CG; Fuqua SA; Klotz DM; Hill SM
    Cancer Res; 1993 Dec; 53(24):5934-9. PubMed ID: 8261406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An estrogen receptor beta isoform that lacks exon 5 has dominant negative activity on both ERalpha and ERbeta.
    Inoue S; Ogawa S; Horie K; Hoshino S; Goto W; Hosoi T; Tsutsumi O; Muramatsu M; Ouchi Y
    Biochem Biophys Res Commun; 2000 Dec; 279(3):814-9. PubMed ID: 11162434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of an estrogen receptor alpha variant protein in cell lines and tumors.
    Fasco MJ; Keyomarsi K; Arcaro KF; Gierthy JF
    Mol Cell Endocrinol; 2000 Aug; 166(2):156-69. PubMed ID: 11203301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of estrogen receptor beta messenger RNA variant in breast cancer.
    Vladusic EA; Hornby AE; Guerra-Vladusic FK; Lupu R
    Cancer Res; 1998 Jan; 58(2):210-4. PubMed ID: 9443393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol regulates alternative splicing of estrogen receptor-alpha mRNA in differentiated NG108-15 neuronal cells.
    Aizawa S; Yamamuro Y
    Life Sci; 2008 Mar; 82(13-14):692-8. PubMed ID: 18258268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis.
    Pujol P; Rey JM; Nirde P; Roger P; Gastaldi M; Laffargue F; Rochefort H; Maudelonde T
    Cancer Res; 1998 Dec; 58(23):5367-73. PubMed ID: 9850067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of wild type and variants of oestrogen receptors in polymorphonuclear and mononuclear leucocytes.
    Stygar D; Westlund P; Eriksson H; Sahlin L
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):74-81. PubMed ID: 16402932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of an alternatively spliced estrogen receptor lacking exon 4 isolated from MCF-7 breast cancer cells and meningioma tissue.
    Koehorst SG; Cox JJ; Donker GH; Lopes da Silva S; Burbach JP; Thijssen JH; Blankenstein MA
    Mol Cell Endocrinol; 1994 May; 101(1-2):237-45. PubMed ID: 9397958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor mRNA splice variants in pre- and postmenopausal human endometrium and endometrial carcinoma.
    Rice LW; Jazaeri AA; Shupnik MA
    Gynecol Oncol; 1997 Apr; 65(1):149-57. PubMed ID: 9103405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer.
    Zhang QX; Borg A; Fuqua SA
    Cancer Res; 1993 Dec; 53(24):5882-4. PubMed ID: 8261397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
    Kinoshita Y; Chen S
    Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The estrogen receptor variant lacking exon 5 has dominant negative activity in the human breast epithelial cell line HMT-3522S1.
    Ohlsson H; Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1998 Oct; 58(19):4264-8. PubMed ID: 9766649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines.
    Pfeffer U; Fecarotta E; Castagnetta L; Vidali G
    Cancer Res; 1993 Feb; 53(4):741-3. PubMed ID: 7916651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.
    Bollig A; Miksicek RJ
    Mol Endocrinol; 2000 May; 14(5):634-49. PubMed ID: 10809228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variant human breast tumor estrogen receptor with constitutive transcriptional activity.
    Fuqua SA; Fitzgerald SD; Chamness GC; Tandon AK; McDonnell DP; Nawaz Z; O'Malley BW; McGuire WL
    Cancer Res; 1991 Jan; 51(1):105-9. PubMed ID: 1988075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer.
    Fuqua SA; Schiff R; Parra I; Friedrichs WE; Su JL; McKee DD; Slentz-Kesler K; Moore LB; Willson TM; Moore JT
    Cancer Res; 1999 Nov; 59(21):5425-8. PubMed ID: 10554010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of estrogen receptor mRNA copy numbers in breast cancer cell lines and tumors.
    Poola I; Williams DM; Koduri S; Ramprakash J; Taylor RE; Hankins WD
    Anal Biochem; 1998 May; 258(2):209-15. PubMed ID: 9570831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
    Campbell-Thompson M; Lynch IJ; Bhardwaj B
    Cancer Res; 2001 Jan; 61(2):632-40. PubMed ID: 11212261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.